Valuation: ASP Isotopes Inc.

Capitalization 936M 806M 751M 699M 1.3B 84.55B 1.39B 8.63B 3.4B 40.42B 3.51B 3.44B 148B P/E ratio 2025 *
-5.98x
P/E ratio 2026 * -13.9x
Enterprise value 936M 806M 751M 699M 1.3B 84.55B 1.39B 8.63B 3.4B 40.42B 3.51B 3.44B 148B EV / Sales 2025 *
102x
EV / Sales 2026 * 23.7x
Free-Float
65.52%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-4.41%
1 week+11.18%
Current month+33.83%
1 month+25.83%
3 months-43.26%
6 months-9.25%
Current year+33.83%
More quotes
1 week 6.91
Extreme 6.91
7.75
1 month 5.24
Extreme 5.2401
8.08
Current year 5.35
Extreme 5.35
8.08
1 year 3.65
Extreme 3.65
14.49
3 years 0.28
Extreme 0.28
14.49
5 years 0.28
Extreme 0.28
14.49
10 years 0.28
Extreme 0.28
14.49
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2025-09-30
Director of Finance/CFO 61 2024-06-30
Chief Operating Officer 47 2026-01-05
Director TitleAgeSince
Chairman 50 2021-09-12
Director/Board Member 67 2021-09-30
Director/Board Member 61 2021-09-30
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-4.41%+11.18%+37.43%+336.59% 936M
-3.76%-4.81%+38.33%+185.65% 925B
+0.47%+6.72%+51.46%+26.60% 529B
-2.32%-3.29%+26.50%+41.11% 383B
+0.46%+1.86%+30.01%+18.51% 368B
-2.23%-1.06%+31.72%+20.33% 291B
-1.36%+0.63%+26.39%+35.48% 274B
-0.04%-0.02%+10.87%-1.14% 275B
-3.45%-1.39%-39.64%-22.02% 252B
+0.32%-0.02%+22.72%+21.46% 178B
Average -1.63%+1.21%+23.58%+66.26% 347.57B
Weighted average by Cap. -1.67%-0.56%+28.02%+63.94%
See all sector performances

Financials

2025 *2026 *
Net sales 9.2M 7.92M 7.38M 6.87M 12.78M 831M 13.71M 84.83M 33.38M 397M 34.49M 33.78M 1.46B 39.44M 33.97M 31.66M 29.45M 54.79M 3.56B 58.78M 364M 143M 1.7B 148M 145M 6.25B
Net income -107M -92.37M -86.08M -80.08M -149M -9.69B -160M -989M -389M -4.63B -402M -394M -16.99B -27.65M -23.82M -22.2M -20.65M -38.42M -2.5B -41.21M -255M -100M -1.19B -104M -102M -4.38B
Net Debt - -
More financial data * Estimated data
Logo ASP Isotopes Inc.
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Employees
136
More about the company
Date Price Change Volume
26-01-15 7.480 $ +5.50% 8,570,272
26-01-14 7.090 $ -0.98% 5,758,285
26-01-13 7.160 $ -4.41% 5,102,105
26-01-12 7.490 $ -0.27% 5,429,100
26-01-09 7.510 $ +16.61% 19,154,904

End-of-day quote Nasdaq, January 12, 2026

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.480USD
Average target price
13.00USD
Spread / Average Target
+73.80%
Consensus

Quarterly revenue - Rate of surprise